Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas
1997

Loss of Heterozygosity in Early Breast Carcinomas

Sample size: 75 publication Evidence: moderate

Author Information

Author(s): SA Chappell, T Walsh, RA Walker, JA Shaw

Primary Institution: Breast Cancer Research Unit, Department of Pathology, University of Leicester

Hypothesis

Is loss of heterozygosity at chromosome 6q an early event in the development of breast cancers?

Conclusion

The study found frequent loss of heterozygosity at chromosome 6q in both preinvasive and early invasive breast carcinomas, suggesting it is an early event in breast cancer development.

Supporting Evidence

  • Loss of heterozygosity was detected at all four loci studied.
  • The frequency of loss of heterozygosity ranged from 23% to 50% depending on the marker.
  • LOH was observed in both high- and low-grade DCIS.
  • 48% of invasive carcinomas showed evidence of LOH.
  • 90% of the invasive carcinomas were oestrogen receptor positive.

Takeaway

The researchers looked at breast cancer samples and found that a lot of them had lost important genetic information, which might help explain how these cancers start.

Methodology

The study used polymerase chain reaction (PCR) analysis to examine loss of heterozygosity at four microsatellite markers in microdissected tumor samples.

Limitations

The study did not include cases from women with a strong family history of breast cancer or known inherited predispositions.

Participant Demographics

The study included 75 early breast carcinoma cases, comprising 59 invasive carcinomas and 16 preinvasive cases of ductal carcinoma in situ (DCIS).

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication